Teva Neuroscience, Inc.
16 drugs in NADAC|0 Generic,16 Brand
Teva Neuroscience, Inc. lists 16 NDCs in the CMS NADAC file (0 generic, 16 brand), at an average NADAC of $244.39 per unit, with a week-over-week move of -0.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
16
0G / 16B
Avg Price / Unit
$244.3894
$44.05 – $541.12
Avg 7d Change
-0.18%
Across 12 drugs with changes
7d Activity
of 16 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
deutetrabenazine market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Monoamine Oxidase Inhibitor therapeutic class
Review the broader class where Teva Neuroscience, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Teva Neuroscience, Inc. make?
Teva Neuroscience, Inc. lists 16 NDCs in the CMS NADAC file — 0 generic and 16 brand products.
What is the average price of Teva Neuroscience, Inc. drugs?
The average NADAC across Teva Neuroscience, Inc.'s portfolio is $244.3894 per unit, ranging from $44.0463 to $541.1156.
What types of drugs does Teva Neuroscience, Inc. make?
Teva Neuroscience, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Monoamine Oxidase Inhibitor (2).
Has Teva Neuroscience, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Teva Neuroscience, Inc. in the openFDA feed.
How has Teva Neuroscience, Inc.'s pricing changed recently?
Over the past 7 days, 3 Teva Neuroscience, Inc. products rose and 9 fell, with a portfolio-wide average change of -0.2%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COPAXONE 40 MG/ML SYRINGE Glatiramer Acetate | $541.1156 per ML | +0.08% |
AUSTEDO XR 48 MG TABLET deutetrabenazine | $500.8437 per EA | -0.23% |
AUSTEDO XR 42 MG TABLET deutetrabenazine | $498.1348 per EA | -0.35% |
AUSTEDO XR 36 MG TABLET deutetrabenazine | $416.7561 per EA | -0.43% |
AUSTEDO XR 30 MG TABLET deutetrabenazine | $332.3400 per EA | -0.21% |
AUSTEDO XR 18 MG TABLET deutetrabenazine | $251.1606 per EA | +0.15% |
AUSTEDO XR 24 MG TABLET deutetrabenazine | $250.6312 per EA | -0.08% |
AUSTEDO XR TITR(12-18-24-30 MG) deutetrabenazine | $249.3230 per EA | — |
COPAXONE 20 MG/ML SYRINGE Glatiramer Acetate | $229.7988 per ML | — |
AUSTEDO XR 12 MG TABLET deutetrabenazine | $166.7645 per EA | -0.10% |
AUSTEDO 12 MG TABLET Deutetrabenazine | $125.0296 per EA | -0.16% |
AUSTEDO 9 MG TABLET Deutetrabenazine | $93.9708 per EA | +0.01% |
AUSTEDO 6 MG TABLET Deutetrabenazine | $83.2000 per EA | -0.12% |
AUSTEDO XR 6 MG TABLET deutetrabenazine | $83.0345 per EA | -0.68% |
AZILECT 1 MG TABLET Rasagiline mesylate | $44.0804 per EA | — |
AZILECT 0.5 MG TABLET Rasagiline mesylate | $44.0463 per EA | — |